This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Steingrub, Jay
| Item Type | Name |
|
Concept
|
Influenza A Virus, H1N1 Subtype
|
|
Concept
|
Influenza B virus
|
|
Concept
|
Influenza, Human
|
|
Concept
|
Influenza A Virus, H3N2 Subtype
|
|
Concept
|
Influenza Vaccines
|
|
Concept
|
Influenza A virus
|
|
Academic Article
|
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND).
|
|
Academic Article
|
Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States.
|
|
Academic Article
|
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates.
|
|
Academic Article
|
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
|
|
Academic Article
|
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.
|
|
Academic Article
|
Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress.
|
|
Academic Article
|
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
|
|
Academic Article
|
Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness.
|
|
Academic Article
|
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
|
|
Academic Article
|
Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022.
|
|
Academic Article
|
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged =60 Years - IVY Network, 20 U.S. States, February 2022-May 2023.
|
|
Academic Article
|
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
|
|
Academic Article
|
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
|
|
Academic Article
|
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023.
|
|
Academic Article
|
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.
|
|
Academic Article
|
Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study.
|
|
Academic Article
|
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022.
|